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https://doi.org/10.1016/j.celrep.2021.109697SUMMARYMidbrain dopaminergic (mDA) neurons are diverse in their projection targets, effect on behavior, and suscep-
tibility to neurodegeneration. Little is known about the molecular mechanisms establishing this diversity dur-
ing development. We show that the transcription factor BCL11A is expressed in a subset of mDA neurons in
the developing and adult murine brain and in a subpopulation of pluripotent-stem-cell-derived human mDA
neurons. By combining intersectional labeling and viral-mediated tracing, we demonstrate that Bcl11a-ex-
pressing mDA neurons form a highly specific subcircuit within the murine dopaminergic system. In the sub-
stantia nigra, theBcl11a-expressingmDA subset is particularly vulnerable to neurodegeneration upon a-syn-
uclein overexpression or oxidative stress. Inactivation of Bcl11a in murine mDA neurons increases this
susceptibility further, alters the distribution of mDA neurons, and results in deficits in skilled motor behavior.
In summary, BCL11A defines mDA subpopulations with highly distinctive characteristics and is required for
establishing and maintaining their normal physiology.INTRODUCTION
Midbrain dopaminergic (mDA) neurons are anatomically orga-
nized into the substantia nigra (SN), ventral tegmental area
(VTA), and retro-rubral field (RRF). These anatomically defined
areas contain subpopulations of mDA neurons that are charac-
terized by distinct connectivity and distinct effects on behavior
(Cox and Witten, 2019; Engelhard et al., 2019; Morales and
Margolis, 2017). The SN consists of the pars compacta (SNc),
containing most SN-mDA neurons; the pars lateralis (SNl); and
the pars reticularis (SNr). SNl mDA neurons project to the tail of
the striatum (TS) (Menegas et al., 2015). Medial SNc mDA neu-
rons send their axons to the dorsomedial striatum (DMS), and
projections of the lateral SNc target the dorsolateral striatum
(DLS) (Lerner et al., 2015). mDA neurons in the VTA project toCel
This is an open access article under the CC BY-Nthe nucleus accumbens (NAc), the olfactory tubercle (OT), pre-
frontal cortex (PFC), and amygdala. The VTA is also anatomically
divided into smaller domains, but the relationship between the
anatomical location of mDA cell bodies and their projection tar-
gets is less well defined (Morales and Margolis, 2017).
In addition to these anatomical mDA subgroups, mDA neurons
have been classified based on their molecular profile. A compar-
ison of the currently available single-cell gene expression studies
led to the proposal that there are at least 7 molecularly defined
mDA subgroups. These subgroups do not necessarily corre-
spond to mDA populations distinct by anatomical location, pro-
jection target, and functional output (Poulin et al., 2020), and
thus, it is not clear to what extent these different levels of diver-
sity can be reduced to a common denominator to definemDA di-
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OPEN ACCESSconnectivity are largely determined during development, a better
understanding of the developmental factors that determine mDA
subpopulations could deliver important new insights on how to
define mDA subpopulations.
mDA neurons in the SNc degenerate in Parkinson’s disease
(PD), leading to the cardinal motor symptoms of PD. mDA neu-
rons in the VTA are much less affected by the neurodegeneration
in PD and in various PD models in rodents, but even within the
SNc, neurons are not homogeneous in their vulnerability: SNc-
mDA neurons in the ventral tier appear to be more vulnerable
than the ones in the dorsal tier (Surmeier et al., 2017). In mouse,
ventral tier neurons express ALDH1A1 (Aldehyde Dehydroge-
nase 1 Family Member A1), whereas the less vulnerable subpop-
ulation in the dorsal tier expresses the Calcium-binding protein
Calbindin1 (CALB1) (Liu et al., 2014; Poulin et al., 2014; Thomp-
son et al., 2005; Wu et al., 2019), suggesting that the susceptibil-
ity to neurodegeneration in mDA subgroups could be genetically
and developmentally pre-determined.
Because transcription factors are key regulators of cell spec-
ification programs, we set out to identify transcription factors
that are expressed in subpopulations of mDA neurons in the
developing and adult brain. We discovered that the C2H2
zinc finger transcription factor BCL11A (B cell CLL/lymphoma
11A) is expressed in a subpopulation of mDA neurons from
embryogenesis to adulthood. BCL11A is a transcriptional
repressor and a dedicated subunit of the mammalian SWI/
SNF complex, which functions as an ATP-dependent chromatin
remodeler (Kadoch et al., 2013; Simon et al., 2020). In mouse,
BCL11A regulates neuronal fate determination during cortex
and spinal cord development (Simon et al., 2020). In humans,
BCL11A haploinsufficiency results in neurodevelopmental dis-
orders characterized by developmental delay, intellectual
disability, and behavioral problems (Basak et al., 2015; Dias
et al., 2016; Fitzgerald et al., 2015; Peron et al., 2019; Soblet
et al., 2018). Although these studies point to the importance
of BCL11A in the development of the central nervous system
(CNS), the function of BCL11A in the development and mainte-
nance of the dopaminergic (DA) system has not yet been
examined.
RESULTS
BCL11A is expressed in a subset of mDA neurons in the
mouse brain
We initially identified Bcl11a as a potential mDA-subset marker
based on the expression pattern available on the Allen BrainFigure 1. BCL11A is expressed in a subset of mDA neurons
(A–F0 ) Immunostaining for TH andmultiplex fluorescent in situ hybridization forBcl
E, and F) Higher magnification of the boxed areas in (A) and (D). (B0, C0, E0, and F0)
express lower levels of Bcl11a mRNA than VTA-mDA neurons, as evident by the
(G–L) Immunostaining for BCL11A and TH on P0 (G–I) and P30 (J–L) coronal se
Immunostaining for BCL11A failed to detect the protein in the SN at P30.
(M–R) Immunostaining for b-gal and TH on coronal sections of P0 (M–O) and P30 (P
in (M) and (P). Yellow arrowheads, cells double positive for TH and BCL11A/Bcl11
negative.
(S and T) Percentage of b-gal-positive TH-expressing neurons in Bcl11a-lacZ mi
(U) Schematic of the SNI, SNc, and VTA level shown in (A)–(R). Error bars indicate
P0), 25 mm (B, C, E, E0, F, F0, H, I, K, L, N, O, Q, and R), and 10 mm (B0 and C0). SAtlas (Developing Mouse Brain). To examine whether BCL11A/
Bcl11a is indeed expressed in a subpopulation of mDA neurons,
we analyzed the expression of Bcl11a mRNA and BCL11A pro-
tein in combination with tyrosine hydroxylase (TH), the rate
limiting enzyme in dopamine synthesis. In the neonatal and post-
natal day 30 (P30) brain, Bcl11a mRNA was expressed in a sub-
set of SN, VTA, RRF, and caudal linear nucleus (CLi) neurons. In
the SN, Bcl11a-expressing mDA neurons were predominantly
localized to the SNl and the dorsal SNc. Within the VTA,
Bcl11a-positive neurons were found primarily in the lateral VTA
(Figures 1A–1F; data not shown). The distribution of neurons
positive for BCL11A protein and TH was comparable to the dis-
tribution ofBcl11a/TH-positive neurons in the neonatal brain and
in the VTA of P30 brains (Figures 1G–1L). However, we could not
detect the BCL11A protein in mDA neurons in the SN at P30 (Fig-
ures 1J and 1L).Bcl11amRNA is expressed at lower levels in SN-
than in VTA-mDA neurons at P30 (Figures 1E and 1F), indicating
that SN-mDA neurons may express the BCL11A protein at low
levels that are undetectable with the anti-BCL11A antibody
used in our study.
Next, we analyzed the distribution of Bcl11a-expressing cells
by using Bcl11alacZ mice. In this mouse line, the lacZ allele is
knocked into the endogenousBcl11a locus and b-gal expression
is restricted to cells that express Bcl11a (Dias et al., 2016).
Indeed, the distribution of b-gal-positive mDA neurons in
neonatal and adult brain was comparable to the one ofmDA neu-
rons expressing Bcl11a mRNA (Figures 1A–1F and 1M–1R; Fig-
ure S1). Double labeling for b-gal and the BCL11A protein
showed that the expression pattern of b-gal and BCL11A was
largely overlapping in the VTA and in the cerebral cortex, indi-
cating that b-gal reliably marks BCL11A-expressing neurons
(Figures S2A–S2D). Quantification of b-gal and TH double-posi-
tive cells in VTA, SN, RRF, and CLi of neonatal and P30 Bcl11a-
lacZ mice demonstrated that about one-third of mDA neurons
express Bcl11a (Figures 1S and 1T; Figure S1G). Additionally,
non-mDA neurons expressing b-gal were present medial to the
VTA, dorsal to the SN, and within the VTA and SN area (Figures
1M and 1P; Figure S1).
An analysis of the developmental time course of BCL11A
expression showed that BCL11A was first expressed in the
ventral midbrain at embryonic day 12.5 (E12.5). At E12.5 and
E13.5, BCL11A was mainly localized in the area just below the
mDA progenitor domain and in a few differentiated TH-express-
ing mDA neurons. At E14.5 and E15.5, expression was found in a
larger subset of mDA neurons in the forming SN and VTA (Figures
S2E–S2I; data not shown).11amRNA on postnatal day 0 (P0) (A–C0) and P30 (D–F0 ) coronal sections. (B, C,
Higher magnification of the boxed area in (B), (C), (E), and (F). SN-mDA neurons
density of fluorescent dots in the TH-positive cell.
ctions. (H, I, K, and L) Higher magnification of the boxed area in (G) and (J).
–R)Bcl11a-lacZmice. (N, O, Q, and R) Higher magnification of the boxed areas
a/b-gal; white arrowheads, cells that express BCL11A/Bcl11a/b-gal but are TH-
ce at P0 (S; n = 5 mice) and P30 (T; n = 6 mice).
mean ± SEM. Scale bars: 200 mm (A, G, G0, M, and M0), 500 mm (D, J, J0, P, and
ee also Figures S1 and S2.
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Figure 2. BCL11A-expressing hiPSC-derived mDA neurons show a distinct gene expression profile
(A and B) Low-dimension uniform manifold approximation and projection (UMAP) of single-cell transcriptomes. Culture of 2,648 hiPSC-derived human mDA
neurons annotated by cell type (as in Fernandes et al., 2020) (A) and normalized for BCL11A expression (B).
(C) BCL11A expression levels (counts per million) detected in single cells aggregated by cell type. Error bars indicate 95% confidence intervals.
(D and E) Gene set enrichment analysis of the top 100 upregulated genes in BCL11A-positive DAn1 (D) or BCL11A-positive DAn4 (E) cells sorted according to
statistical significance. See also Tables S1 and S2. For subtype characterization in mouse see Figure S3.
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OPEN ACCESSBCL11A-expressing human-stem-cell-derived mDA
neurons show a distinct gene expression profile
To examine whether BCL11A is expressed in human mDA
neurons, we analyzed data obtained from droplet-based sin-
gle-cell RNA sequencing (scRNA-seq) of human induced
pluripotent stem cell (hiPSC)-derived mDA neurons. These
cultures contain multiple neuronal subtypes, including SNc-
like (DAn1) and VTA-like (DAn4) mDA neurons as well as
progenitor cells (Prog1 and Prog2) and neurons with charac-
teristics that do not fully recapitulate in vivo mDA neuronal4 Cell Reports 36, 109697, September 14, 2021types (DAn2 and DAn3) (Figure 2A; Fernandes et al.,
2020). DAn4 neurons were characterized by the combined
expression of CALB1, MARCK5, and NEFM. DAn1 neurons
were defined by the expression of TH, NR4A2, FOXA2,
LMX1A, DDC, and LMO3 and the absence of serotonergic
markers (TPH1). In these cultures, BCL11A single-cell detec-
tion rates suggested some cell-type specificity with the most
prominent expression in DAn4 neurons followed by expres-




OPEN ACCESSWe then investigated whether BCL11A-expressing mDA neu-
rons show a distinct transcriptomic signature (Fernandes et al.,
2020). Due to the high dropout rates of BCL11A, we were con-
strained to analyses between BCL11A-positive cells and
BCL11A-negative cells in DAn1 (SNc-like) and DAn4 (VTA-like)
cell types. A differential expression analysis of 162 positive and
1,107 negative DAn1 cells using a p value threshold of 0.05 high-
lighted 257 upregulated and 301 downregulated genes in the
DAn1 population. BCL11A expression in DAn4 cells was found
to be broader, with 81 positive and 276 negative cells with differ-
ential expression analysis identifying 167 upregulated and 70
downregulated genes. We then performed a gene set enrich-
ment analysis of the 100 most significant upregulated genes in
DAn1 and DAn4 BCL11A-positive cells. This analysis highlighted
changes in cell projection morphogenesis, synaptic transmis-
sion, and synapse organization pathways for DAn1 BCL11A-ex-
pressing cells (Figure 2D; Table S1). In DAn4 BCL11A-positive
cells, the analysis revealed prominent changes in translation
(Figure 2E; Table S2). Taken together, BCL11A defines a distinct
molecular signature within SNc-like (DAn1) and VTA-like (DAn4)
hiPSC-derived mDA neurons. In DAn1 neurons, this gene
expression profile suggests that neuronal maturation and func-
tion of BCL11A-expressing neurons may differ from BCL11A-
negative DAn1 neurons.
Based on the differential expression analysis in hiPSC-
derived mDA, BCL11A-expressing neurons do not fall into
any of the previously characterized mDA subclasses (Poulin
et al., 2020). To examine this in the mouse brain, we focused
on the mDA subpopulations expressing ALDH1A1, CALB1,
and SOX6 (SRY-Box Transcription Factor 6). ALDH1A1 is ex-
pressed in the ventral VTA, whereas CALB1 shows widespread
expression in the VTA (Thompson et al., 2005; Wu et al., 2019).
SOX6 expression is restricted to SN-mDA neurons and to neu-
rons of the lateral VTA (Panman et al., 2014; Poulin et al., 2018).
We performed triple immunostaining for b-gal, TH, and the
respective subset marker (ALDH1A1, CALB1, or SOX6) in
neonatal and P30 brain of Bcl11a-lacZ mice (Figures S3A–
S3D). Quantification of triple-labeled mDA neurons (Figures
S3E–S3H) showed that Bcl11a-expressing mDA neurons did
not fully overlap with any of these markers, confirming that
Bcl11a-positive mDA neurons do not clearly fall within one of
these mDA subpopulations.
Bcl11a-expressingmDAneurons forma subcircuit in the
DA system
If Bcl11a-expressing neurons indeed constitute a subset in the
DA system, they should feature not only a specific molecular
profile but also specific connectivity patterns. To examine
whether the Bcl11a-expressing subclass of mDA neurons con-
tributes to specific subcircuits in the mDA system, we specif-
ically labeled cell bodies and projections of Bcl11a-expressing
mDA neurons by using an intersectional genetic approach. This
method is based on a reporter construct in which expression of
a fluorescent protein is driven by a tetracycline response
element (TRE) in a Cre-dependent manner (Madisen et al.,
2015; Poulin et al., 2018). We first combined the intersectional
reporter mouse line Ai82D (Madisen et al., 2015) with a DattTA
(tetracycline trans-activator driven by the Dat promoter) and aBcl11aCreER mouse line (Chen et al., 2015; Poulin et al., 2018;
Pensa et al., 2021; Figure 3A). Because BCL11A expression
is already restricted to mDA subsets during embryogenesis
(Figures S2F–S2I), CreER was activated by administering
tamoxifen to pregnant females at E15.5 (Figure 3B). Distribution
of the recombined (EGFP+) mDA neurons was comparable to
the distribution of b-gal-expressing cells in Bcl11a-lacZ mice
(Figures 3C, S1, and S4). An analysis of EGFP-positive fibers
showed that in target areas of VTA-mDA neurons (Morales
and Margolis, 2017), Bcl11a-expressing mDA neurons strongly
innervated the lateral septum and the OT and the ventral and
lateral shell of the NAc, but not the medial shell or core (Figures
3D and 3E; data not shown). Hardly any EGFP-positive fibers
were observed in the amygdala, habenula, or PFC (data not
shown). Moreover, Bcl11a-expressing mDA neurons showed
a highly specific projection pattern to the TS and the caudal
DMS (Figures 3D and 3E), which are target areas of mDA neu-
rons in the SNl and the medial SNc, respectively (Lerner et al.,
2015; Menegas et al., 2015; Poulin et al., 2018). Within these
SN target areas, the densest innervation originating from re-
combined mDA neurons was observed in the ventral TS. Inner-
vation of the dorsolateral and rostral striatum was very sparse.
Next, we investigated the projections of mDA neurons that
express Bcl11a in the adult brain (1) to clarify whether Bcl11a
expression defines the same subset of mDA neurons in the em-
bryonic and adult brain and (2) to clearly delineate the projec-
tion targets of Bcl11a-expressing neurons in the SN versus in
the VTA. We introduced reporter constructs by injecting recom-
binant adeno-associated viruses (rAAVs) into the SN or VTA of
adult animals. CreER was subsequently activated by the
administration of tamoxifen to achieve recombination (Figures
4A and 4B; Figures S5A and S5B). We took both an intersec-
tional approach, in which we introduced an intersectional re-
porter construct into Bcl11aCreER, DattTA mice (Figures 4A and
4B), and a non-intersectional approach in which we delivered
a Cre-dependent reporter construct into Bcl11aCreER mice (Fig-
ures S5A and S5B). Labeling of Bcl11a-expressing mDA neu-
rons in the SN was scarcer than that in the VTA (Figures 4C,
4D, 4F, and 4G; Figures S5C, S5D, S5G, and S5H), which is
consistent with a lower percentage of Bcl11a-expressing
mDA neurons in the SN than in the VTA (Figure 1T). The sparse
labeling allowed us to visualize patches of innervation likely
derived from single SN axons. These patches were restricted
to the DMS and ventral TS, consistent with the findings ob-
tained with the embryonically induced intersectional labeling
(Figure 3D; Figures 4E and 4E’; Figures S5E and S5F’). Charac-
terization of the VTA projection targets showed strong innerva-
tion of the OT and the ventral and lateral shell of the NAc (Fig-
ures 4F–4I; Figures S5G–S5K), consistent with the innervation
pattern observed with the embryonic labeling (Figure 3). In
some animals (n = 6/10) with sparse labeling of Bcl11a-ex-
pressing VTA-mDA neurons, the OT was innervated in a
stripe-like pattern, suggesting that axons from single neurons
might target specific domains within the OT (Figure S5I). In
conclusion, these results show that expression of Bcl11a in
embryogenesis and adulthood defines subsets of SN and
VTA mDA neurons that form a highly specific subcircuit within





Figure 3. Bcl11a-expressing mDA neurons contribute projections to subcircuits of the dopaminergic system
(A) Intersectional fate mapping strategy to label Bcl11a-expressing mDA neurons and their projections. Bcl11aCreER mice were used in combination with DattTA
mice and an intersectional reporter mouse line (Ai82D). EFGP is expressed only in cells positive for both CreER and tTa and only after CreER is activated by
tamoxifen administration.
(B) Experimental timeline.
(C) Distribution of mDA neurons labeled with the intersectional fate mapping approach (EGFP+ and TH+) for individual mice (1–7). SN: l_SNc, lateral SNc; m_SNc,
medial SNc; and SNl; VTA: IF, infundibular nucleus; PBP, parabrachial nucleus; and PN, paranigral nucleus (see Figure S1F). Colored circles are matched with the
colors of the projection analysis in (E).
(D) Quantification of the density of mDA axons labeled with the intersectional fate mapping approach (EGFP+) in olfactory tubercle (OT), nucleus accumbens core
(NacC), nucleus accumbens shell (NacSh), rostral striatum (RS), dorsomedial striatum (DMS), dorsolateral striatum (DLS), and ventral and dorsal tail of striatum
(vTS and dTS, respectively). n = 7 mice. Error bars indicate mean ± SEM.
(E) Projections of mDA axons labeled with the intersectional fate mapping approach (EGFP+) in five rostrocaudal striatal coronal sections shown for individual
mice (indicated by different colors, as in C). TH-positive fibers are shown in gray. Scale bars: 500 mm.
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OPEN ACCESSConditional gene inactivation of Bcl11a in mDA neurons
results in altered positioning of Bcl11a-mDA neurons
Because BCL11A is a transcription factor that has been shown
to influence neuronal fate, neuronal morphology, and migration
(Simon et al., 2020), we investigated whether BCL11A is neces-
sary for establishing and/or maintaining Bcl11a-expressing
mDA neurons. We generated a specific knockout for Bcl11a
in mDA neurons by crossing Bcl11aflox mice with DatIRES-Cre
mice (Bcl11a ckoflox; genotype: DatIRES-Cre/+, Bcl11aflox/flox)
(Bäckman et al., 2006; John et al., 2012). In a subset of mice,
we introduced the Bcl11alacZ allele (a null allele; Dias et al.,
2016) into the conditional knockout model (Bcl11a ckolacZ; ge-
notype: DatIRES-Cre/+, Bcl11aflox/lacZ) (Figure 5A). In Bcl11a cko-
lacZ mice, the Bcl11a-expressing mDA population expresses
b-gal even after inactivation of Bcl11a, allowing us to analyze
the effect of Bcl11a inactivation specifically in mDA neurons
that would normally express BCL11A (termed Bcl11a-mDA
neurons, b-gal and TH positive) (Figure 5B). We performed im-
munostaining and multiplex fluorescent in situ hybridization
confirming that the BCL11A protein and Bcl11a mRNA expres-
sion were indeed absent in mDA neurons of Bcl11a ckoflox
mice. As expected, BCL11A/Bcl11a was still expressed in
non-mDA neurons in the midbrain and cerebral cortex
(Figure S6).
The anatomical organization of the mDA area in Bcl11a con-
ditional knockout (cko) (both in Bcl11a ckoflox and Bcl11a cko-
lacZ) mice was comparable to that of controls (Figures 5C and
5D; data not shown), and the overall percentage of Bcl11a-
mDA neurons (SN plus VTA) was not significantly changed be-
tween Bcl11a ckolacZ and Bcl11-lacZ mice (Figures 5E and 5F).
However, a detailed analysis by anatomical area and levels re-
vealed alterations in the distribution of Bcl11a-mDA neurons in
P30 Bcl11a ckolacZ mice. The percentage of Bcl11a-mDA neu-
rons was significantly increased in the CLi and significantly
decreased at the most rostral level of the VTA (Figures 5F,
S7A, and S7B). No significant rostral-to-caudal shift in the per-
centage of Bcl11a-mDA neurons could be detected in the SNc
or SNl of Bcl11a ckolacZ mice, but in the rostral SNc, Bcl11a-
mDA were shifted from medial to lateral as compared to con-
trols (Figures 5G, S7C, and S7D). These results indicate that
the specific inactivation of Bcl11a in mDA neurons does not
interfere with the generation or the survival of the Bcl11a-
mDA neuronal population but that it results in altered posi-
tioning of Bcl11a-mDA neurons in the VTA and SNc.
If BCL11A is important for determining the localization of
mDA neurons, it may also influence cell fate by regulating the
expression of subset markers or the target specificity of
Bcl11a-mDA projections. However, triple labeling for b-gal,
TH, and CALB1 at P0 and P30; for b-gal, TH, and SOX6 at
P0; and for b-gal, TH, and ALDH1A1 at P30 did not reveal a sig-Figure 4. Bcl11a-expressing mDA neurons of the VTA and SN show a
(A) Injection of rAAV with an intersectional reporter construct into the SNc or VTA
(B) Experimental timeline. Tamoxifen administration 8 days after rAAV injection r
neurons.
(C–E0) Immunostaining for TH and EYFP in the SN (C–D0) and the tail of the striat
(F–I) Immunostaining for TH and EYFP in the VTA (F–G0), striatum (H), and NAc and
for SN injections, n = 3 mice for VTA injections. Scale bars: 500 mm (C, F, and H
8 Cell Reports 36, 109697, September 14, 2021nificant change in the number of Bcl11a-mDA neurons co-ex-
pressing these markers in Bcl11a ckolacZ mice as compared
to Bcl11a-lacZ mice (Figures S7E–S7J and S3). To assess the
targeting of projections arising from Bcl11a-mDA neurons, we
examined the density of TH innervation in control and Bcl11a
cko mice in the ventral TS and the OT (the two areas with the
highest innervation density from Bcl11a-mDA neurons) and in
the dorsal striatum and the dorsal TS. We found no significant
difference in the density of the TH innervation in any of these
areas when comparing control and Bcl11a cko mice (Figures
S7K–S7Q). These data suggest that the inactivation of Bcl11a
has no overt effect on the anatomy of Bcl11a-mDA neuronal
projections.
Inactivation of Bcl11a in mDA neurons results in skilled
motor learning deficits
To investigate whether the specific inactivation ofBcl11a in mDA
neurons leads to functional impairment in the DA system, we
examined behaviors associated with VTA and/or SN function in
Bcl11a cko and control mice. In the open field, distance moved
was not altered in Bcl11a cko mice as compared to controls,
indicating that spontaneous motor behavior was not affected
in the mutant mice (Figure 6A). Decreased dopamine release
from the VTA is associated with anxiety- and depressive-like
behavior, which can be assessed by monitoring the activity in
the center of an open field (Tye et al., 2013; El Yacoubi et al.,
2003). Bcl11a cko mice did not show a change in the frequency
of crossing into the center and time spent in center or border
area in the open field, indicating that the Bcl11a cko mice did
not have an increased level of anxiety or depressive behavior
(Figures 6B and 6C). Next, we focused on tasks in which
dopamine release from SN-mDA neurons is thought to play a
prominent role. Dopamine release in the striatum is crucial for
voluntary movement and motor skill learning (Cox and Witten,
2019; Dodson et al., 2016; Wu et al., 2019). Motor coordination
and balance were examined by monitoring the ability of mice
to cross a balance beam (Luong et al., 2011). We found no differ-
ence in the performance of Bcl11a cko mice and control mice in
this task (Figure 6D). To examine whether motor skill learning is
altered in Bcl11a cko mice, mice had to perform an accelerating
rotarod test (Costa et al., 2004). In this task, control mice
improved their performance over time, as reflected in a contin-
uous increase in the time to fall over a 5-day training period. In
contrast,Bcl11a ckomice did not show any improvement in their
performance over time, indicating that they were not able to learn
this skilledmotor task within the trial period (Figure 6E). These re-
sults show that the specific inactivation of Bcl11a in mDA neu-
rons results in deficits in skilled motor learning and suggest
that Bcl11a-mDA neurons are functionally impaired in the
absence of BCL11A.specific innervation pattern of forebrain targets
of Bcl11aCreER/+;DattTA/+ mice.
esults in expression of the reporter protein (EYFP) in Bcl11a-expressing mDA
um (TS) (E and E0).
OT (I). Yellow arrows, neurons positive for TH and reporter protein. n = 2 mice








Figure 5. BCL11A is necessary for establishing the correct anatomical position of Bcl11a-expressing mDA neurons
(A) Conditional gene inactivation of Bcl11a in mDA neurons. Bcl11a cko mice were generated by crossing DatIRES-Cre mice with Bcl11aflox/flox mice (genotype:
DatRES-Cre/+, Bcl11aflox/flox, termed Bcl11a ckoflox) or with Bcl11aflox/lacZ mice (genotype: DatIRES-Cre/+, Bcl11aflox/lacZ, termed: Bcl11a ckolacZ).
(B) In Bcl11a ckolacZ mice, b-gal is a marker for Bcl11a-mDA neurons even after BCL11A expression is abolished.
(legend continued on next page)






OPEN ACCESSBCL11A acts a neuroprotective factor in SNc-mDA
neurons
The next set of experiments was aimed at elucidating the role of
BCL11A in the context of neuronal challenges and neurodegen-
erative processes affecting mDA neurons in the SNc. The protein
a-synuclein plays a key role in the pathogenesis of PD and other
human neurodegenerative diseases (Goedert et al., 2013). Its
overexpression in animal models is associated with PD-like pa-
thology, including the degeneration of SNc-mDA neurons and
accumulation of modified a-synuclein forms (Migdalska-Ri-
chards et al., 2017; Ulusoy and Di Monte, 2013). Adult control
(n = 5) and Bcl11a cko (n = 5) mice were challenged with a single
intraparenchymal injection of rAAVs carrying the DNA for human
a-synuclein (Figure 7A). The unilateral injection targeted the right
SNc where it caused robust overexpression of human a-synu-
clein within SNc-mDA neurons. Immunostaining against human
a-synuclein showed no difference in overexpression between
control and Bcl11a cko mice (Figure 7B).
Next, TH immunoreactivity was compared in the intact and in-
jected side of the SNc in animals sacrificed 8 weeks after rAAV
injection. Labeling was overtly less robust in the lesioned SNc
of both control and Bcl11a cko mice, but the reduction in TH
immunoreactivity appeared to be more pronounced in Bcl11a
cko animals (Figure 7C). Stereological counts in the intact SNc
were similar between control and Bcl11a cko mice and were
therefore averaged together as normal values (5,988 ± 79.4
cells). Overexpression of a-synuclein caused a 15% reduction
of TH+ neurons in the lesioned SNc of control mice (5,086 ±
292.8 cells). This loss was significantly more pronounced
(4,231 ± 208.2 cells) inBcl11a ckomice (Figure 7D). The possibil-
ity that the decrease in neuronal counts after rAAV injection may
reflect a downregulation of TH expression rather than actual cell
degeneration was ruled out by counting the total number of
Nissl-stained neurons. This number declined by 12% (from
9,185 ± 141.4 to 8,070 ± 525.6) and 27% (to 6,741 ± 326.1) in
the lesioned SNc of control and Bcl11a cko mice, respectively
(Figure 7E). Hyperphosphorylation is a consequence of intra-
neuronal a-synuclein accumulation and a marker of pathological
changes in a-synuclein conformation and aggregation (Fujiwara
et al., 2002; Migdalska-Richards et al., 2017). Midbrain sections
from control and Bcl11a cko mice with rAAV-induced a-synu-
clein overexpression were immunostained with an antibody
recognizing a-synuclein phosphorylated at Ser129 (p129-a-syn-
uclein). Staining for p129-a-synuclein was virtually absent within
SNc neurons on the intact side of the SNc (data not shown),
whereas robust immunoreactivity characterized neurons in the
injected SNc, consistent with an accumulation of pathological
a-synuclein. The density of labeled neurons was decreased in
the right SNc of Bcl11a cko mice as compared to control mice,(C–D0 0) Immunostaining for b-gal and TH on coronal sections of P0 (C–C0 0) and P
(E and F) Quantification of TH+ b-gal+ neurons, expressed as the percentage of
percentage of mDA neurons expressing b-gal in Bcl11a ckolacZ mice (n = 5) is not
the percentage of Bcl11a-mDA neurons is significantly increased in the CLi of Bc
(G) Relative contribution of b-gal-positive TH neurons to themedial and lateral SNc
a significant medial-to-lateral shift in the position of Bcl11a-mDA neurons at the m
followed by Sı́dák’s multiple comparison test (F) andWelch’s ANOVA followed by
SEM. Scale bars: 200 mm (C–C0 0) and 500 mm (D–D0 0’). See also Figures S6 and S
10 Cell Reports 36, 109697, September 14, 2021likely reflecting the more pronounced nigral cell loss seen in
Bcl11a-deficient animals (Figure 7F). Taken together, these find-
ings reveal that vulnerability to a-synuclein toxicity is markedly
enhanced in the absence of BCL11A and support the notion
that BCL11A expression is associated with the transcription of
genetic information involved in neuroprotective pathways.
The Bcl11a-expressing SNc-mDA neuronal
subpopulation is highly vulnerable to toxic insults
Additional experiments using the same paradigm of rAAV-
induced a-synuclein overexpression were carried out in Bcl11a
ckolacZ (n = 4) and Bcl11a-lacZ (genotype: Bcl11aflox/lacZ) control
(n = 5) mice. Like the results in Bcl11a cko animals without the
lacZ allele, a-synuclein toxicity caused a more severe loss of
TH-positive neurons in the SNc of Bcl11a ckolacZ mice (from
5,954 ± 71.1 to 3,349 ± 193.3 cells) than that of Bcl11a-lacZ
controls (from 5,954 to 5,041 ± 81.6 cells) (Figure 7G). In these
experiments, confocal stereological counts were also able to
distinguish the effects of a-synuclein overexpression on
Bcl11a-mDA neurons in the SNc (TH+ and b-gal+) versus SNc-
mDA neurons devoid of Bcl11a (TH+ and b-gal). In Bcl11a-
lacZ mice, 30% of b-gal+ neurons (from 1,899 ± 70.8 to 1,332
± 93.7 cells) degenerated because of a-synuclein overexpres-
sion, whereas no statistically significant changes were observed
in the number of b-gal mDA cells between the lesioned and
intact SNc (from 4,055 ± 118.8 to 3,709 ± 83.5 cells) (Figure 7H).
These data indicate that Bcl11a expression characterizes a sub-
population of SNc-mDA neurons highly susceptible to a-synu-
clein-induced damage.
The number of b-gal+ and b-gal neurons was then counted in
the SNc of Bcl11a ckolacZ animals. Results showed more dra-
matic toxic effects because a-synuclein toxicity killed almost
65% (from 1,899 to 664 ± 117.0 cells) and 34% (from 4,055 to
2,685 ± 91.4 cells) of b-gal+ and b-gal cells, respectively (Fig-
ure 7I). Thus, in the absence of BCL11A expression, Bcl11a-
mDA neurons became even more vulnerable to neurodegenera-
tion, consistent with the protective role of BCL11A-mediated
transcription described in the previous section. Interestingly, in
Bcl11a ckolacZ mice, neuronal cell death also affected b-gal
mDA neurons. This latter finding suggests that inactivation of
Bcl11amay have cell non-autonomous effects resulting in wide-
spread deleterious consequences for nigral tissue integrity.
To further explore the vulnerability of Bcl11a-expressing SNc-
mDA neurons to toxic insults, we analyzed scRNA-seq data from
hiPSC-derived mDA neurons that were treated with rotenone to
induce oxidative stress (Fernandes et al., 2020). Rotenone treat-
ment significantly reduced the proportion of SNc-like mDA
neurons (DAn1; Figure 2A). Further investigation highlighted a
subpopulation of DAn1 cells sensitive to rotenone. Because30 (D–D0 0 ) Bcl11a ckolacZ mice.
control (Bcl11a-lacZ mice; control values in Figures 1S and 1T). (E) At P0, the
significantly changed compared to that of Bcl11a-lacZmice (n = 5). (F) At P30,
l11a ckolacZ mice (n = 6) as compared to those of Bcl11a-lacZ mice (n = 6).
at different rostrocaudal midbrain levels at P30. InBcl11a ckolacZmice, there is
ost rostral level of the SNc. Statistical significance was determined by ANOVA
Dunnett’s T3multiple comparison test (G). *p < 0.05. Error bars indicate mean ±
7.
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Figure 6. Inactivation of Bcl11a in mDA neurons results in specific defects in learned motor behavior
(A–C) Open field test (5-min timewindow) revealed no significant difference betweenBcl11a ckoflox (cko) and control mice (ctr) in distancemoved (A), in time spent
in the center or border area (B), or the frequency of entering the center (C).
(D) Mice had to balance on a beam toward a food reward. The test was performed on 5 consecutive days. The ability of Bcl11a cko to cross a balance beam was
not impaired.
(E) The rotarod test revealed that Bcl11a cko mice were not able to learn the motor task because the time to fall did not increase in Bcl11a cko mice within the
5 days of the trial period. Bcl11a cko (n = 12) and control mice (n = 13). Significance was determined by two-way ANOVA. ***p < 0.001, ****p < 0.0001. p = 7.226e-
10 for genotype, p = 0.0002017 for days, and p = 0.0076354 for interdependence between days and genotypes. Error bars indicate mean ± SEM.
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OPEN ACCESSthis subpopulation was absent from the rotenone-treated
culture, we inferred those sensitive cells by mapping transcrip-
tomes from the treated DAn1 cells to the untreated culture pop-
ulation. Cells with no pair in the untreated population were
considered sensitive to rotenone. Interestingly, these rotenone-
sensitive DAn1 cells had a distinct transcriptomic profile, with
BCL11A more likely to be detected within single cells in this
group than the rest of the non-sensitive DAn1 cells (BCL11A-
negative cells: 407 depleted, 495 survived; BCL11A-positive
cells: 83 depleted, 63 survived; Fisher’s exact test for count
data, p value = 0.00945). Together with our results from the
Bcl11a-lacZ mice, these data indicate that both in mouse brain
and in human in vitro models the Bcl11a/BCL11A-expressing
mDA-SNc neuronal subpopulation is more susceptible to toxic
insults than other mDA-SNc neuronal populations.
DISCUSSION
mDA neurons are diverse in their gene expression, their anatom-
ical location, their projection targets, and their electrophysiolog-
ical and functional properties (Farassat et al., 2019; Morales and
Margolis, 2017; Poulin et al., 2020; Roeper, 2013). How thesedifferent features of mDA diversity are related is not yet clear
but is the subject of intense research. For example, a number
of recent studies have shown that subsets of mDA neurons
sharing expression of specificmarkers have also specific projec-
tion targets in the forebrain (Bimpisidis et al., 2019; Heymann
et al., 2020; Khan et al., 2017; Kramer et al., 2018; Poulin et al.,
2018). However, how and whether such subsets are already
defined during development remain unclear.
Here, we show that the expression of the transcription factor
BCL11A defines subpopulations of mDA neurons starting from
embryogenesis and throughout adulthood in the mouse and in
iPSC-derived human mDA neurons. Bcl11a is expressed in
many types of neurons in almost every region of the CNS (Allen
Brain Atlas), but its function has been studied only in a few
regions so far (Simon et al., 2020). In the cortex, BCL11A is
important for the specification of cortical neurons that project
to subcerebral areas (Cánovas et al., 2015; Woodworth et al.,
2016), and it controls the acquisition of sensory area identity
and the establishment of sensory input fields (Greig et al.,
2016). Moreover, BCL11A regulates themigration of cortical pro-
jecting neurons (Wiegreffe et al., 2015). In the dorsal spinal cord,



































































































































Figure 7. a-Synuclein toxicity is enhanced in the absence of BCL11A
(A) Mice received a unilateral intraparenchymal injection of rAAVs carrying the DNA for human a-synuclein (ha-syn) into the SNc.
(B–F) Control (n = 5) and Bcl11a cko (n = 5) mice were sacrificed 8 weeks after treatment with ha-syn-AAVs. (B) Midbrain coronal sections comprising the SNc
(delineated with dotted lines at low magnification) were immunostained with anti-human a-synuclein antibody to detect expression of the transduced protein in
control and Bcl11a cko mice. Right panels: higher magnification of the boxed areas. (C) Midbrain sections were immunostained for TH (brown staining) and
counterstained with cresyl violet (purple). Left panels: lesioned (AAV-injected) sides. Right panels: contralateral intact sides. (D and E) TH-immunoreactive (D) and
Nissl-stained (E) neurons were counted stereologically in the intact (left) and lesioned (right) SNc of control (n = 5) and Bcl11a cko (n = 5) mice. Intact side values
from control and cko animals were pooled (dark gray bars). Light-gray and empty bars show average values from the lesioned side of control (ctr) and cko mice,
respectively. (F) Midbrain sections were immunostained for p129 a-synuclein. Representative images show labeledmDA cell bodies in the SNc; the square boxes
encompass areas of the SNc that are shown at higher magnification (insets).
(G–I) Bcl11a-lacZ control (n = 5) and Bcl11a ckolacZ (n = 4) mice were sacrificed 8 weeks after treatment with ha-syn-AAVs. Midbrain sections from Bcl11a-lacZ
control (n = 5) and Bcl11a ckolacZ (n = 4) mice were double stained with anti-TH and anti-b-gal antibodies. (G) Total neurons (b-gal-negative and b-gal-positive TH
cells) were counted in the SNc of Bcl11a-lacZ and Bcl11a ckolacZ mice using confocal stereology. (H) The number of TH/b-gal-positive and TH/b-gal-negative
(legend continued on next page)






OPEN ACCESScircuit formation (John et al., 2012). Whether it functions purely
as a transcriptional repressor or also as part of the chromatin re-
modeling complex in these neurons remains to be investigated
(see Introduction). In mDA neurons, the inactivation of Bcl11a re-
sults in a rostral-to-caudal shift in the position of Bcl11a-mDA
neurons in the VTA and a medial-to-lateral shift in the rostral
SNc, suggesting that BCL11A might play a role in regulating
the expression of factors that control the migration of mDA neu-
rons. In the cerebral cortex, BCL11A regulates cortical neuron
migration by controlling the expression of Semaphorin 3c (Wie-
greffe et al., 2015), a cell adhesionmolecule that is not expressed
in mDA neurons (Kolk et al., 2009). An analysis of the scRNA-seq
data for BCL11A-positive and BCL11A-negative cells in the
hiPSC-derived DAn1 and DAn4 population showed that in
BCL11A-positive cells, genes encoding components of the cyto-
skeleton or cytoskeleton-associated proteins known to be
involved in the regulation of neuronal migration are differentially
expressed (e.g., doublecortin-like kinase, neuronal navigator 1,
tubulin beta 2 chain in DAn1; Rac1, microtubule associated pro-
tein 1B and tubulin beta 2 chain in DAn4) (Breuss et al., 2017;
Deuel et al., 2006; Kawauchi, 2015; Koizumi et al., 2006; Sán-
chez-Huertas et al., 2020; Villarroel-Campos and Gonza-
lez-Billault, 2014).Thus, inactivation of Bcl11a in mDA neurons
could result in changes in cytoskeleton dynamics that contribute
to altered neuronal migration and positioning of mDA neurons in
Bcl11a cko mice.
In humans, pathogenic variants of BCL11A (mostly de novo
mutations) result in neurodevelopmental disorders that have
recently been classified as BCL11A-related intellectual disabil-
ities (Peron et al., 2019). This syndrome is characterized by gen-
eral developmental delay, microcephaly, speech delay, and
behavioral problems, as well as several non-CNS-related pheno-
types. In some affected individuals, seizures or autism spectrum
disorder have been reported. Given the widespread expression
of BCL11A in the brain, it is unclear if any of these neurological
symptoms in patients are associated with functional deficits in
the DA system. Moreover, there are no reports of neurodegener-
ative phenotypes, but long-term observations of patients or case
studies in adult or aged patients are not available, due to the
limited number of cases reported and the bias toward diagnosis
in childhood (Peron et al., 2019).
DA subcircuits may encode a precise behavioral output by tar-
geting a set of substructures within the DA projection targets, and
a few studies have shown that specific subcircuits within themDA
system regulate very specific aspects of behavior (Engelhard
et al., 2019; Heymann et al., 2020; Menegas et al., 2018). Whether
such behavioral modules are consistent with genetically deter-
mined populations is just starting to be examined (Heymann
et al., 2020).Bcl11a-mDAneurons of the VTAproject to themedial
and ventral shell of the NAc and the OT, whereas Bcl11a-mDA
neurons of the SN show a highly selective innervation of the
ventral TS and the caudal DMS. This specific innervation pattern
suggests that this genetically defined subpopulation may modu-neurons was counted in the SNc of Bcl11a-lacZ mice. (I) The number of TH/b-g
ckolacZ animals. For these analyses, counts in the intact SNc showed no differenc
was determined by one-way ANOVA followed by Tukey’s post hoc test for multiple
± SEM. Scale bars: 100 mm (low-magnification panels in B, C, and F), 20 mm (higlate a specific subset of dopamine-influenced behaviors. Indeed,
inactivation of Bcl11a in mDA neurons results in a specific behav-
ioral impairment in skilled motor learning, whereas spontaneous
motor behavior or coordination is not affected. Because Bcl11a
is specifically inactivated in mDA neurons in our conditional
knockout mouse model, this behavioral phenotype is most likely
caused by functional changes inmDA neurons rather than by def-
icits in othermidbrain neurons, cerebellum, ormotor cortex (Hiko-
saka et al., 2002; Li et al., 2017). Potential functional changes
upon Bcl11a inactivation in mDA neurons, such as altered
neuronal activity and/or a decrease in dopamine release, are
apparently severe enough to elicit a behavioral phenotype. It will
have to be explored in the future how Bcl11a inactivation alters
Bcl11a-mDA neurons at a functional level. Such studies are
complicated by the fact that only relatively small areas are densely
innervated by Bcl11a-mDA neurons and that Bcl11a-mDA neu-
rons constitute only a subset of mDA neurons. To date,
BCL11A has not been directly linked to the regulation of neuronal
activity. However, the fact that haploinsufficiency for BCL11A in
humans leads to intellectual disability and BCL11A is a risk
gene for autism spectrum disorder (as described above) indicate
that BCL11A may influence neuronal activity not only by affecting
brain development but also by directly regulating the expression
of genes important for neuronal function inmature neurons (Peron
et al., 2019; Satterstrom et al., 2020). Another line of evidence
supporting a function of Bcl11 genes in regulating neuronal activ-
ity comes from studies of the closely related Bcl11b in hippocam-
pal neurons. Inactivation of Bcl11b in the adult brain leads to
changes in hippocampal synapse formation and maintenance
as well as electrophysiological deficits (e.g., massively impaired
LTP) (De Bruyckere et al., 2018; Simon et al., 2016).
Dopamine release in the dorsal striatum appears to be essen-
tial for learning skilled motor behavior. Partial ablation of mDA
projections using 6-hydroxydopamine (6-OHDA) in rats does
not affect spontaneousmotor behavior in the open field or on bal-
ance beam, but it strongly interferes with the ability of the animals
to improve their performance on the rotarod (Ogura et al., 2005).
Recent evidence suggests that the precise timing of dopamine
signals influences the performance of highly skilled motor
behavior in an immediate and a long-term manner (Bova et al.,
2020). It has been proposed that the plasticity in striatal medium
spiny neurons underlying initial skill learning during goal-directed
actions requires dopamine release in the DMS, whereas dopa-
mine release in the DLS is important for optimal skill learning
(Durieux et al., 2012; Graybiel, 2008). Based on this model and
our observation that Bcl11a-mDA neurons in the SNc project to
the DMS but not the DLS, the deficit in motor learning could
have its origin in the inability of the mice to initiate the learning
of skilled motor behavior. Interestingly, the ablation of Aldh1a1-
expressing mDA neurons leads to an impairment in motor skill
learning on the rotarod that is similar to the one observed in
Bcl11a cko mice even though Aldh1a1-expressing neurons proj-
ect almost exclusively to the DLS (Wu et al., 2019). Thus, it isal-positive and TH/b-gal-negative neurons was counted in the SNc of Bcl11a
e between the two groups of animals and were therefore pooled. Significance
comparisons (D, E, andG) or Student’s t test (H and I). Error bars indicatemean
her magnification panels in B), and 50 mm (higher magnification panels in F).
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OPEN ACCESSpossible that altered dopamine release either in DMS and DLS
and thus defects in both phases of learning lead to a similar over-
all defect in the acquisition of skill learning.
The mDA neurons in the ventral tier of the SNc have been char-
acterized as beingmost vulnerable to neurodegeneration in PD as
well as in animal models of the disease (Surmeier et al., 2017).
Based on some PD models in rodents, the most vulnerable pop-
ulation appears to coincide with ALDH1A1-expressing SNc-mDA
neurons (Poulin et al., 2014). On the other hand, ALDH1A1-nega-
tive SNc-mDA neurons are more vulnerable to overexpression of
a-synuclein with a disease-relevant mutation (a-synuclein A53T)
in a transgenic mouse model (Liu et al., 2014). Here, we demon-
strate that Bcl11a-mDA neurons in the SNc, which are mostly
located in the dorsal tier and are largely ALDH1A1 negative, are
highly susceptible to neurodegeneration upon a-synuclein over-
expression (mouse) or rotenone exposure (human). Thus, our
data suggest that there are also differences in the vulnerability
of mDA neurons within the dorsal tier of the SNc and that
BCL11A serves as a marker for the more vulnerable mDA
neuronal population within the dorsal tier. In the mouse brain,
these Bcl11a-mDA neurons project to the caudal DMS, which
corresponds roughly to the caudate nucleus in the human brain
(Burton et al., 2015). Some of the early symptoms associated
with PD are assumed to be based on functional deficits of the
caudate nucleus (rapid eye movement sleep behavior disorder
and gait problems), and a recent study demonstrated a significant
DA de-innervation of the caudate nucleus in about one-half of the
examined patients in the early stage of PD (Pasquini et al., 2019),
suggesting that caudate-projectingmDAneuronsmay also forma
vulnerable population in humans.BCL11A is expressed in hiPSC-
derived mDA neurons (our data) and in human mDA neurons (La
Manno et al., 2016), but further studies will be necessary to eval-
uate which subpopulations express this transcription factor in the
human DA system and whether the reduced DA innervation of the
caudate nucleus in early PD may be associated with a specific
loss of BCL11A-expressing mDA neurons in patients.
Although Bcl11a-mDA SNc neurons are more susceptible to
a-synuclein-induced degeneration, BCL11A also acts as a neuro-
protective factor in this population because the loss of Bcl11a-
mDA neurons is significantly more severe in Bcl11a ckolacZ mice
than in Bcl11a-lacZ mice. BCL11A could be modulating cell sur-
vival directly because it has been shown to regulate expression
of the anti-apoptotic factor BCL2 in early B lymphocytes and inac-
tivation of Bcl11a in cortical projection neurons results in
increased cell death (Wiegreffe et al., 2015; Yu et al., 2012). An
analysis of scRNA-seq data of BCL11A-positive and BCL11A-
negative cells in the DAn1 population shows that several genes
or pathways that have previously been implicated in neurodegen-
erative processes are differentially expressed in BCL11A-positive
neurons. These include genes encoding for microtubule-associ-
ated proteins (described above: doublecortin-like kinase,
neuronal navigator 1, and tubulin beta 2 chain). By regulating
the expression of these genes, BCL11A could affect the balance
between stable and dynamic microtubules. Because perturban-
ces in microtubule dynamics might contribute to neurodegenera-
tive processes, this could be one potential pathway regulated by
BCL11A contributing to its role as a neuroprotective factor (Calo-
gero et al., 2019; Dubey et al., 2015). In addition, we find that14 Cell Reports 36, 109697, September 14, 2021NSC1 (neuronal Ca2+ sensor 1) transcripts are upregulated in
the BCL11A-expressing human DAn1 population. NCS1 acts as
a neuroprotective factor potentially by shielding SNc-mDA neu-
rons from Ca2+ overload, which arises from the particular activity
patterns (pacemaker activity) and low Ca2+ buffering capacities of
SNc-mDA neurons. Inactivation of NCS1 in mice aggravates neu-
rodegeneration in the SNc, and NCS1 levels are reduced in iPSC-
derived mDA neurons from patients with familiar PD (Benkert
et al., 2019; Surmeier et al., 2017). If BCL11A positively regulates
NCS1 expression, a loss of BCL11A could lead to reduced NSC1
levels, which could contribute to increased susceptibility of these
neurons to neurodegeneration. Future studies will have to investi-
gate whether these mechanisms underlie the function of BCL11A
in neurodegeneration and neuroprotection in both mouse and hu-
man mDA neurons.
CONCLUSIONS
Our data demonstrate that the expression of Bcl11a defines sub-
populations ofmDA neurons in the SNc and VTA that forma highly
specific subcircuit within the DA system. We show in the mouse
DA system and in hiPSC-derived mDA neurons that the Bcl11a-
expressing mDA neurons in the SNc show distinct susceptibility
to toxic insults. The loss of BCL11A function in these neurons in-
terferes with their functional integrity and their resilience to neuro-
degeneration. It will be of great interest to investigate whether the
subcircuits formed byBcl11a-expressing mDA neurons comprise
a specific functional module in the DA system and to understand
the gene regulatory networks downstream of BCL11a that affect
the (patho)physiology of this subpopulation of mDA neurons.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d RESOURCE AVAILABILITYB Lead contact
B Materials availability
B Data and code availability
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Tamoxifen administration
B Tissue processing
B Multiplex fluorescent in situ hybridization
B Stereotactic viral vector injection
B Image acquisition
B Quantification of cell numbers
B Stereology
B Analysis of fiber density
B Behavioral tests
B Single cell RNA-sequencing
d STATISTICAL ANALYSIS
SUPPLEMENTAL INFORMATION





This work was supported by the German Research Foundation (BL 767/2–1,
BL 767/3–1, BL 767/4–1, 417960915 to S. Blaess), the SFB 1089 (to M.T., S.
Blaess, and K.M.J.v.L.), the Maria von Linden-Program (University of Bonn
to S. Blaess), and the Ministerium f€ur Kultur und Wissenschaft des Landes
Nordrhein-Westfalen (R€uckkehrer-Programm to S. Blaess). Further support
was obtained from the Innovative Medicines Initiative 2 (IMI-2 821522; PD-Mi-
toQUANT to D.A.D.M.), and EU Joint Programme-Neurodegenerative Disease
(JPND 01ED2005B to D.A.D.M.). N.P. has been supported by UK Dementia
Research Institute grant RRZA/175. S. Britsch has been supported by grants
from the German Research Foundation (BR 2215/1-1 and 2215/1-2). We thank
Neal Copeland and Nancy Jenkins for agreeing to provide the Bcl11a floxed
mouse line; the UKB microscopy core facility for support with imaging; the
UKB virus core for providing AAVs; Milan Pabst and Heinz Beck for support
with stereotactical injections; Alesja Dernst, Philipp Grunwald, and JulianWirtz
for technical support; and Norisa Meli for critical reading of the manuscript.
The graphical abstract was created with biorender.com.
AUTHOR CONTRIBUTIONS
M.T., data curation, formal analysis, validation, investigation, visualization,
methodology, writing—original draft, writing—review and editing; A.U., data
curation, formal analysis, validation, investigation, visualization, methodology,
writing—review and editing; K.U.S.I., investigation, visualization, methodol-
ogy, writing—review and editing; N.P., data analysis—single-cell transcrip-
tomics, visualization—single-cell transcriptomics, methodology—single-cell
transcriptomics, writing—review and editing; G.O.B., investigation, visualiza-
tion, methodology, writing—review and editing; E.Ö., B.B., A.M., and A.W.,
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B., Broberger, C., Hnasko, T.S., and Wallén-Mackenzie, Å. (2019). The Neu-roD6 subtype of VTA neurons contributes to psychostimulant sensitization
and behavioral reinforcement. Eneuro 6, ENEURO.0066-19.2019.
Bova, A., Gaidica, M., Hurst, A., Iwai, Y., Hunter, J., and Leventhal, D.K. (2020).
Precisely timed dopamine signals establish distinct kinematic representations
of skilled movements. eLife 9, e61591.
Breuss, M.W., Leca, I., Gstrein, T., Hansen, A.H., and Keays, D.A. (2017). Tu-
bulins and brain development - The origins of functional specification. Mol.
Cell. Neurosci. 84, 58–67.
Burton, A.C., Nakamura, K., and Roesch, M.R. (2015). From ventral-medial to
dorsal-lateral striatum: neural correlates of reward-guided decision-making.
Neurobiol. Learn. Mem. 117, 51–59.
Calogero, A.M., Mazzetti, S., Pezzoli, G., and Cappelletti, G. (2019). Neuronal
microtubules and proteins linked to Parkinson’s disease: a relevant interac-
tion? Biol. Chem. 400, 1099–1112.
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goat anti-b-gal Biogenesis, Kinsgton,NH, USA Validated in Alvarez-Bolado et al., 2012
guinea pig anti-BCL11A First described in John et al., 2012 N/A
mouse anti-human a-synuclein Merck, Darmstadt, DE RRID: AB_310817
mouse anti-TH Merck, Darmstadt, DE RRID:AB_2201528
rabbit anti-ALDH1A1 Sigma-Aldrich, St. Louis, MO, USA RRID:AB_1844722
rabbit anti-Calbindin Swant, Herford, DE RRID:AB_2314067
rabbit anti-RFP Rockland-inc, Hamburg, DE RRID:AB_2209751
rabbit anti-SOX6 Abcam, Cambridge, UK RRID:AB_1143033
rabbit anti-TH Merck, Darmstadt, DE RRID:AB_390204
rat anti-GFP Nalacai Tesque, Kyoto, JP RRID:AB_10013361
Cy3-Streptavidin Jackson ImmunoResearch, Ely,
Cambridgeshire, UK
RRID:AB_2337244
donkey anti-goat Cy3 Jackson ImmunoResearch, Ely,
Cambridgeshire, UK
RRID:AB_2307351
donkey anti-guinea pig Biotin Jackson ImmunoResearch, Ely,
Cambridgeshire, UK
RRID:AB_2340451
donkey anti mouse-Alexa 488 Thermo Fischer Scientific, Waltham, MA,
USA
RRID:AB_141607
donkey anti mouse-Alexa 647 Thermo Fischer Scientific, Waltham, MA,
USA
RRID:AB_162542
donkey anti rabbit-Alexa 488 Thermo Fischer Scientific, Waltham, MA,
USA
RRID:AB_2535792
donkey anti rabbit-Alexa 546 Thermo Fischer Scientific, Waltham, MA,
USA
RRID:AB_2534016
donkey anti rabbit-Alexa 647 Thermo Fischer Scientific, Waltham, MA,
USA
RRID:AB_2536183
donkey anti rat-Alexa 488 Thermo FischerScientific, Waltham, MA,
USA
RRID:AB_2535794
Chemicals, peptides and recombinant proteins
Ampuwa water Ampuwa, Fresenius 40676.00.00
Aqua-PolyMount Polysciences Inc. 18606
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DNA Ladder 100bp Thermo Fisher Scientific 15628019
DNA Ladder 1Kb Plus Thermo Fisher Scientific 10787-018
dNTPs (100mM) GE Healthcare 28-4065-52
EDTA Merck E6511
Ethidium bromide Carl Roth 2218.2
Ethylene glycol Merck 1009492500
Glacial acetic acid Merck A6283-1L
Glycerol Sigma Aldrich G5516
Hoechst 33258 Abcam ab228550
Magnesium chloride (MgCl2) VWR 25108.260
Normal donkey serum (NDS) Jackson ImmunoResearch 017-000-121
Paraformaldehyde (PFA) Carl Roth 0335.2
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Potassium chloride (KCl) VWR 26764.260
Potassium phosphate monobasic (KH2PO4) Merck P9791
RNase away Roche 13398800
Sodium bicarbonate (NaHCO3) VWR 27775.293
Sodium chloride (NaCl) VWR 27788.297
Sodium dihydrogen phosphate (NaH2PO4
2H2O)
VWR 28013.264
Sodium hydroxide (NaOH) VWR 31627.290
Sodium phosphate (Na2HPO4) VWR 28028.298
Sucrose Sigma Aldrich 27480.360
Tamoxifen Sigma Aldrich T5648-5G
Taq DNA polymerase recombinant Thermo Fischer Scientific 10342-020
Tissue Tek O.C.T. Sakura 4583
Transcription Buffer (10x) Roche 10881767001
Tris-HCl Merck 108219.1000
Triton X-100 Merck 1.08219.1000
Tween-20 VWR 28829.183
Xylene cyanol Sigma Aldrich 335940-10G
Bacterial and virus strains
AAV1/2-EF1a-DIO-ChR2-eYFP UKB Viral Core Facility, Bonn, DE N/A
pAAV-EF1a-double floxed-hChR2(H134R)-
mCherry-WPRE-HGHpA
Addgene, Watertown, MA, USA 20297-AAV1
AAV1/2-EF1a-pTRE-FLEX-ChETA-eYFP UKB Viral Core Facility, Bonn, DE N/A




Advanced Cell Diagnostic 323110
Mm-Bcl11a-C3 RNA probe Advanced Cell Diagnostic N/A
Deposited data
Imaging and quantitative data Mendeley Data Mendeley Data:
https://doi.org/10.17632/4h9265nnrf.1
scRNaseq data Fernandes et al., 2020 ArrayExpress: E-MTAB-9154
Experimental models: Cell lines
KOLF-2 iPSC (human) HipSci RRID:CVCL_9S58
Experimental models: Organisms/strains
Ai82D (TITL-GFP) The Jackson Laboratory RRID: MGI: J:219930
Bcl11aCreER Dr. Walid Khaled, University of Cambridge Pensa et al., 2021
Bcl11aflox Dr. Pentao Liu, The University of Hong
Kong; Prof. Stefan Britsch, University of
Ulm;
RRID: J:194616
Bcl11alacz Dr. Pentao Liu, The University of Hong Kong RRID: J:219746
DATIRES-Cre The Jackson Laboratory RRID: MGI: J:114466
DattTA The Jackson Laboratory RRID: MGI: J:218892
Oligonucleotides
Primers for Ai82D, see Table S3 The Jackson Laboratory N/A
Primers for Ai9, see Table S3 The Jackson Laboratory N/A
Primers for Bcl11a-flox, see Table S3 This paper N/A
Primers for Cre, see Table S3 The Jackson Laboratory N/A
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
Primers for Cre-ER, see Table S3 The Jackson Laboratory N/A
Primers for Dat-tTa, see Table S3 The Jackson Laboratory N/A
Primers for LacZ, see Table S3 The Jackson Laboratory N/A
Software and algorithms
Affinity Designer 1.5.5 Serif, Notthingham, UK https://affinity.serif.com/en-gb/
RRID: SCR_016952
Affinity Photo 1.5.5 Serif, Notthingham, UK https://affinity.serif.com/en-gb/
RRID: SCR_016951
EthoVision XT version 9.0 Noldus, Wageningen, NL https://www.noldus.com/ethovision-
xt RRID: SCR_000441












Stereo Investigator 9 MFB Biosciences, Williston, VTA, USA https://www.mbfbioscience.com/
stereo-investigator. RRID: SCR_002526
VisiView Visitron Systems https://www.visitron.de/products/
visiviewr-software.html







Further information and requests for resources and reagents should be directed to the Lead Contact, Sandra Blaess (sblaess@
uni-bonn.de).
Materials availability
This study did not generate new unique reagents.
Data and code availability
d The accession number for the scRNA sequencing is ArrayExpress: E-MTAB-9154, as reported in Fernandes et al. (2020). Im-
aging and quantitative data have been deposited at Mendeley and are publicly available as of the date of publication. DOIs are
listed in the Key resources table.
d This paper does not report original code.
d Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bcl11alacZ mice (Dias et al., 2016) were kindly provided by Pengtao Liu, School of Biomedical Sciences, The University of Hong Kong,
China. Bcl11afloxmice (Wiegreffe et al., 2015) were kindly provided by Pengtao Liu, School of Biomedical Sciences, The University of
Hong Kong, China; and Neal Copeland, Institute for Academic Medicine, Houston Methodist and obtained from Stefan Britsch, Uni-
versity of Ulm. Bcl11aCreER mice (Pensa et al., 2021) were kindly provided byWalid Khaled, Department of Pharmacology, University
of Cambridge. Bcl11a cko mice were generated by crossing DatIRES-Cre mice (Bäckman et al., 2006) with Bcl11aflox mice (Genotype:
DatRES-Cre/+, Bcl11aflox/flox). In a subset of Bcl11a ckomice, the Bcl11alacZ null allele was introduced by crossingDatIRES-Cremice with
Bcl11aflox/lacZ mice (Genotype: DatIRES-Cre/+, Bcl11aflox/lacZ). Intersectional fate mapping experiments were performed by crossinge3 Cell Reports 36, 109697, September 14, 2021
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OPEN ACCESSBcl11aCreERmice with the DattTA (tetracycline trans-activator driven by the Dat promoter) mouse line (Chen et al., 2015) and the inter-
sectional reporter mouse line Ai82D (Ai82(TITL-GFP)-D (Madisen et al., 2015) (Genotype:Bcl11aCreER/+, DattTA/+, Ai82DTITL-GFP/+). For
viral tracings, Bcl11aCreER/+ or Bcl11aCreER/+, DattTA/+ (intersectional) were used. Mice were kept on a mixed C57BL6/CD1 back-
ground. Developmental stages are indicated in the Results and Figure legends or in the methods section (for behavioral analysis
and a-synuclein overexpression experiments). Mice were group housed in a controlled environment, with 12 hr light/night cycles
and ad libitum availability of food and water. Day of vaginal plug was recorded as E0.5. All experiments were performed in strict
accordancewith the regulations for thewelfare of animals issued by the Federal Government of Germany, European Union legislation
and the regulations of the University of Bonn. The protocol was approved by the Landesamt f€ur Natur, Umwelt und Verbraucher-
schutz Nordrhein-Westfalen (Permit Number: 84-02.04.2014.A410, 84-02.04.2016.A238 and 84-12.04.2015.A550). Both female
and male mice were used for multiplex RNA in situ analysis, immunostaining, viral tracing experiments and a-synuclein overexpres-
sion. Male mice were used for behavioral experiments. For comparison of Bcl11a cko and control mice, littermates were used (from
several litters).
Tamoxifen administration
Tamoxifen was administered by oral gavage to pregnant dams at E15.5 (0.05 ml/10 g body weight) or to adult mice (0.075 ml/10 g
body weight) to labelBcl11a-expressing neurons. Tamoxifen (Sigma Aldrich) was prepared as a 20mg/mL solution in corn oil (Sigma
Aldrich).
Tissue processing
Pregnant females were sacrificed by cervical dislocation. Embryoswere transferred into ice cold PBS, decapitated and dissected. P0
pups were decapitated, and their brain dissected in ice cold PBS. Heads (E12.5 – E15.5) or brains (P0) were fixed in 4% paraformal-
dehyde (PFA) overnight at 4C. Adult mice were anesthetized with an intraperitoneal injection of Ketanest/Rampun or pentobarbital
and subsequently perfused transcardially with phosphate buffered saline (PBS), followed by 4% PFA. The tissue was cryopreserved
in OCT Tissue Tek (Sakura). Embryonic and P0 tissue was cryosectioned at 14 mm thickness and collected on glass slides, adult
brains were cryosectioned at 40 mm thickness and free-floating sections were collected in anti-freeze solution.
For immunofluorescent staining, sections were re-fixed in 4%PFA for 10min at room temperature (RT) and incubated in 10%NDS
in PBS plus 0.2% Triton X-100 (Sigma-Aldrich) (0.2% PBT, used for embryonic and P0 tissue) or in 10% NDS in 0.5% PBT (adult
tissue) for 1 hr at RT. Sections were incubated with primary antibody overnight at 4C in 3% NDS in 0.2% PBT (embryonic and
P0 tissue) or in 3% NDS in 0.3% PBT (adult tissue). For staining with the guinea pig anti-BCL11A antibody and in some cases for
rabbit anti-TH antibody sections were incubated in the primary antibody for 72 hr at RT (guinea pig anti-BCL11A) or at 4C (rabbit
anti-TH antibody). Sections were washed 3 times for 5-10 min in 0.2% PBT (embryonic and P0 tissue) or in 0.3% PBT (adult tissue)
and incubated for 2 hr at RT in secondary antibody in 3% NDS in 0.2% PBT (embryonic and P0 tissue) or in 3% NDS in 0.3% PBT
(adult tissue). Sections were washed 3 times for 5-10 min in 0.2% PBT (embryonic and P0 tissue) or in 0.3% PBT (adult tissue) and
mounted with Aqua Polymount (Polysciences Inc.). For the detection of BCL11A, biotinylated donkey anti-guinea pig antibody fol-
lowed by Cy3-Streptavidin was used.
Processing of tissue from mice overexpressing a-synuclein involved post-fixation with 4% PFA for 24 hr followed by cryopreser-
vation in 30% sucrose solution. Sections were cut at 35 mm thickness using a freezingmicrotome. Staining of these sections followed
previously described protocols (Helwig et al., 2016). A list of primary and secondary antibodies is provided in Key resources table.
The following primary antibody dilutions were used: 1:500 to 1:1000 for rabbit anti-TH, 1:500 formouse anti-TH and rabbit anti-SOX6,
1:1000 for rabbit anti-ALDH1A1 and rabbit anti-RFP, 1:2000 for goat anti-b-gal and rat anti-GFP, 1:2500 for guinea pig anti-BCL11A,
1:5000 for rabbit anti-Calbindin and 1:20.000 for mouse anti-human a-synuclein. Biontinylated donkey anti-guinea pig antibody was
used at a 1:200 dilution and Cy3-streptavidin at a 1:1000 dilution. Cy3-conjugated anti-goat Cy3 and all Alexa fluorophore-conju-
gated secondary antibodies were used at a 1:500 dilution.
Multiplex fluorescent in situ hybridization
Multiplex fluorescent RNA in situ hybridization on frozen sections from P0 and adult mice was performed using RNAscope Fluores-
cent Multiplex Detection Reagents (323110, ACDBio, Newark, CA, USA) according to the instructions provided by the manufacturer
for frozen tissue (UserManual: 323100-USM). Hybridized probewas detected with TSA Plus Cyanine 3 (NEL760001KT, Perkin Elmer,
Waltham,MA, USA). The probe forBcl11awas designed by ACDBio (Cat No. 563701-C3). Sections were counterstained with TH and
Hoechst, then mounted with Aqua Polymount (Polysciences Inc., Warrington, PA, USA).
Stereotactic viral vector injection
Viral tracing
Bcl11aCreER andBcl11aCreER,DattTamice (4-20weeks old) were anesthetizedwith Fentanyl/Midazolam/Medetomidin and placed into
a stereotaxic apparatus. 1 mL of virus solution with a titer of Titer R 1 3 1013 vg/mL (AAV1/2-EF1a-pTRE-FLEX-ChETA-eYFP or
AAV1/2-EF1a-DIO-ChR2-eYFP (both from UKB viral core facility, Bonn, DE) or AAV1/2-EF1a-DIO-ChR2-mCherry (Addgene, Water-
town, MA, USA)) was injected unilaterally into the SNc (from Bregma: anteroposterior (AP), 2.3 mm; mediolateral (ML), 1.1 mm;
dorsoventral (DV),4.1mm) or into the VTA (fromBregma: AP,3.44mm;ML,0.48mm; DV,4.4mm). A 34 g beveled needle (WPI)Cell Reports 36, 109697, September 14, 2021 e4
Article
ll
OPEN ACCESSand a microinjection pump (WPI) were used to control the injection speed (100 nl/min). After the injection, the syringe was kept in
place for 3 min and slowly retracted over 1 min. 8 days after viral injections Tamoxifen was administered to the mice by oral gavage
(0.075 ml/10 body weight) for 3 consecutive days. Two weeks after the last Tamoxifen administration, mice were perfused.
Alpha-Synuclein overexpression
Recombinant adeno-associated viral particles (serotype 2 genome and serotype 6 capsid) were used to express human a-synuclein
in themouse substantia nigra. Gene expressionwas controlled by the humanSynapsin 1 promoter and enhanced using awoodchuck
hepatitis virus post-transcriptional regulatory element and a polyA signal downstream to the a-synuclein sequence. AAV-vector pro-
duction, purification, concentration, and titration were performed by Sirion Biotech (Martinsried, Germany). Mice (5-8 months for
comparison between Bcl11a ckoflox and control mice; 5-16 months for comparison between Bcl11a ckolacZ and Bcl11a-lacZ
mice) were treated with a single 1.5 ml injection of 4.0x1012 genome copies/ml using a stereotaxic framewith amouse adaptor (Stoelt-
ing, Wood Dale, IL, USA) under isoflurane anesthesia. Stereotaxic coordinates were 2.3 mm posterior and 1.1 mm lateral to bregma;
injection depth was 4.1 mm relative to dura mater. The injection was made at a rate of 0.4 ml/min using a Hamilton syringe fitted to a
glass capillary. The capillary was left in position for an additional 5 mins before being retracted. A list of AAVs is provided in Key re-
sources table.
Image acquisition
Images of fluorescently stained images were acquired at an inverted Zeiss AxioObserver Z1 equipped with structured illumination
(ApoTome) and a Zeiss AxioCam MRm (Carl Zeiss, Oberkochen, DE). At 10X (EC PlnN 10x/0.3, Carl Zeiss, Oberkochen, DE) magni-
fication, tile imageswere acquiredwith conventional epifluorescence. At 20X (ECPlnN 20x/0.5, Carl Zeiss, Oberkochen, DE), 40X (Pln
Apo 40x/1.3 Oil, Carl Zeiss, Oberkochen, DE) and 63X (Pln Apo 63x/1.4 Oil, Carl Zeiss, Oberkochen, DE) magnifications, structured
illumination was used to acquire tile images and z stacks. Some of the images taken with the 20X objective and all the images taken
with the 40X and 63X objective are maximum intensity projections of z stacks. Tile images were stitched with Zen blue software
(Zeiss, 2012).
Brightfield images were visualized with a Zeiss Axio Scope.A1 microscope, collected using AxioCam 503 Color and processed
with Zen blue software (Zen lite, 2019).
In situ hybridized sections at adult stageswere imaged at an inverted Zeiss AxioObserver equippedwith aCSU-W1Confocal scan-
ner unit (50 mm pinhole disk, Yokogawa, Tokyo, JP). At 40X (C-Apochromat, 40x/1.2 water, Zeiss) magnification, tile images and z
stacks were acquired with laser lines 405 nm, 488 nm and 561 nm. Images taken with the 40X objective are maximum intensity pro-
jections of z stacks. Tile images were stitched with VisiView software (Visitron Systems, Puchheim, DE).
Quantification of cell numbers
TH+ b-gal+ neurons and additional subset markers
The percentage ofBcl11a-expressingmDA neurons in SN or VTA at P0 and P30was determined by quantifying TH+ b-gal+ neurons at
four (P0) or three (P30) rostrocaudal midbrain levels (Franklin and Paxinos, 2007). TH+ b-gal+ neurons in CLi and RRF in the adult brain
were analyzed separately from neurons in the SN or VTA. The number of TH+ b-gal+ neurons was counted unilaterally in the SN, VTA,
RRF andCLi and normalized for the total number ofmDA neurons per region separately. The analysis was performed on n = 5Bcl11a-
lacZ control mice and n = 5 Bcl11a ckolacZ mice at P0, and on n = 6 Bcl11a-lacZ (control) mice and n = 6 Bcl11a ckolacZ mice at P30.
The percentage of Bcl11a-expressing mDA neurons co-expressing additional subtype markers (SOX6 and CALB1 at P0; CALB1 and
ALDH1A1 at P30) in SN or VTA was determined by quantifying TH+ b-gal+ neurons at four rostrocaudal midbrain levels (Franklin and
Paxinos, 2007). The number of TH+ b-gal+ neurons co-expressing the respective subset marker in these regions was counted unilat-
erally and the numbers were normalized for the total number of TH+ b-gal+ mDA neurons in each region (SN or VTA). This analysis was
performed for n = 5Bcl11a-lacZmice and n = 5Bcl11a ckolacZmice at P0 and for n = 3Bcl11a-lacZmice and n = 3Bcl11a ckolacZmice
at P30.
Stereology
Analyses were performed on SNc samples by an investigator blinded to the sample codes. Unbiased stereological estimates of the
number of nigral neurons were obtained by counting under brightfield or confocal microscopy. Samplings were performed on every
fifth section throughout the entire SNc. Delineations were made using a 4x objective, and counting was performed using a 63x Plan-
Apo oil objective (Numerical aperture = 1.4). A guard zone thickness of 1 mmwas set at the top and bottom of each section. Cells were
counted using the optical fractionator technique (Stereo Investigator software version 9,MBFBiosciences,Williston, VTA, USA) using
a motorized Olympus microscope (IX2 UCB) equipped with an Olympus disk spinning unit (DSU) and a light sensitive EM-CCD cam-
era. Coefficient of error was calculated according to (Gundersen and Jensen, 1987); values < 0.10 were accepted.
Analysis of fiber density
TH-expressing fibers
40 mm sections of 3 to 6 rostrocaudal levels of the striatum were stained for TH and epifluorescence images were taken using and
inverted Z1 Axioobserver microscope with 10X objective. The mean gray value of the TH+ striatal projections was calculated in the
dorsal striatum, OT and TS (divided into ventral and dorsal TS) with Fiji/ImageJ and normalized for background fluorescence (corpuse5 Cell Reports 36, 109697, September 14, 2021
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P30.
EGFP-expressing fibers (intersectional genetic labeling)
40 mm sections of 5 rostrocaudal levels of the striatum were stained for TH and EFGP and epifluorescence images were taken using
an inverted Z1 Axioobserver microscope with 10X objective. Themean gray value of the EGFP+ projections was calculated in the OT,
NAc (divided into core and shell of the NAc), the rostral striatum (RS), DS (divided into medial and lateral DS) and TS (divided into
ventral and dorsal TS) with Fiji/ImageJ and normalized for background fluorescence (cortex which is devoid of EGFP+ fibers).
More specifically, EGFP+ fibers in the OT were analyzed at Bregma 1.42mm, 0.95mm, 0.62 mm and 0.15 mm. For the analysis
of EGFP+ projections to the NAc core and shell and the RS, the mean gray value was calculated at Bregma 0.95mm and
1.42mm, respectively. EGFP+ fibers in the medial and lateral DS were analyzed at Bregma 0.62 mm and 0.15 mm, while those
in the dorsal and ventral TS were analyzed at Bregma 0.58mm. The analysis was performed for 7 mice at P30.
EGFP-expressing fibers (stereotactic viral vector injections)
40 mm sections from one to three rostrocaudal levels of the striatum per animal were stained for TH and EFGP and epifluorescence
images were taken using and inverted Z1 Axioobserver microscope with 10X objective. The mean gray value of the EGFP+ projec-
tions was calculated in the OT (devided into medial and lateral OT) and NAc (divided into core and shell of the NAc) with Fiji/ImageJ.
Subsequently, the background fluorescence (cortex which is devoid of EGFP+ fibers) was subtracted and the obtained value normal-
ized for the average gray value of the analyzed areas to account for differences in recombination efficiencies between animals. This
analysis was performed for 6 mice.
Behavioral tests
Male mice were kept ad libitum in groups of 2-3 animals in a 12-hour day/night rhythm on a normal diet. Animals ranging from two to
four months of age were transferred to the examination room for experimental purposes and each one was housed in a separate
cage. After a one-week acclimatization period in the examination room, mice performed the rotarod test and beam walking assay
(both tests in one day) for five consecutive days, followed by a social recognition test (data not shown) and finally by the open-field
test. All behavioral tests were performed with the experimenter being blinded to the genotype of the mice.
RotaRod
The animals were taken out of the cage and were acclimated to the rotarod apparatus (Ugo Basile, Gemonio, IT; Code no. 47600) in a
5-minute run on a rod rotating at a constant speed of 8 rpm. Afterward the animals went through three test runs per day, with a break
of 30 min between each run. In each test run, the animals had to balance on the rotating rod for 5 min, whereby the torque increased
from 4 to 40 rpm within 5 min. The duration that each mouse was able to stay on the rotating rod in each trial was recorded as the
latency to fall. The three test runs per day were repeated on 5 consecutive days. During the test, the rod was kept clean and dry by
wiping the mouse urine and feces off.
Beam Walking Assay
To examine fine motor skills independent of rotational movement (Luong et al., 2011), the beam walking assay (balanced beam test)
was used (Carter et al., 1999). Animals had to balance from one platform over a 12 mm wide and 1 m long rod made of synthetic
material to another platform that held a box with a food reward. Beams were placed 50 cm above the table. The time taken for
the animals to cross the bar was measured. If animals did not reach the safety platform or took longer than 60 s to cross the
beam, a maximum of 60 s was assigned. The test was run for a period of 5 consecutive days.
Open-field test
In the open-field test, the mice were placed in an open arena (303 303 30 cm). They were allowed to move freely for 5 minutes. The
animals were recorded by Video (EthovisionXT, Noldus,Wageningen, NL) and the running distance, the time spent in the border area,
the corners and the center of the cage as well as crossings from the border to the center area were measured. This test was initially
run for a training period of 1 day, then after a 30-day rest period another test run was performed. This test was run twice with a 30-day
rest period in between. Since both runs showed comparable results, the results were combined for the final analysis.
Single cell RNA-sequencing
Processing, QC and normalization
The single-cell dataset used with the same processing QC and cell type annotation as described in Fernandes et al. (2020).
BCL11A Expression Visualization
To show BCL11A single cell expression on the uniform manifold approximation and projection (UMAP), BCL11A transcript counts
were normalized by their cell’s total detected transcripts, scaled to 10000 reads/cell and then log-normalized. For the barplots
the BCL11A transcripts for every single-cell were transformed to counts per million. The error bars correspond to the variation
observed within the cell type including dropouts.
BCL11A DAn1 transcriptomic signature and gene set enrichment analysis
To define genes that are related to BCL11A expression we split the DAn1 cells into two groups: BCL11A+ cells with at least 1 tran-
script and BCL11A- cells, with no detected transcripts. To identify differentially expressed genes we removed the BCL11A expres-
sion values from the transcriptome, since this was the main criterion of separation, and used scanpy (Wolf et al., 2018) to perform theCell Reports 36, 109697, September 14, 2021 e6
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ering the first 100 upregulated differential expressed genes shorted by according to their statistical test p value.
Neuronal vulnerability in BCL11A+ DAn1 neurons
To assess how relevantBCL11A expression is to neuronal vulnerability we examined two events in every DAn1 neuron: a) whether it is
annotated as sensitive to rotenone treatment as described in (Fernandes et al., 2020) and b) whether BCL11A is detectable. We
examined the relation of those two events using the Fisher’s Exact test on the whole DAn1 population.
STATISTICAL ANALYSIS
Statistical analyses of cell numbers were performedwith GraphPad Prism (9.0) software using unpaired t test andWelch’s t test when
comparing two groups and one-way ANOVA followed by test for linear trend, one-way ANOVA followed by Tukey’s or Sı́dák’s mul-
tiple comparison test or Welch’s ANOVA followed by Dunnett’s T3 multiple comparison test when comparing multiple groups.
Welch0s t test and Welch0s ANOVA were performed for groups of data that were sampled from Gaussian populations, but did not
have the same standard deviation. Statistical analyses of behavioral experiments were donewith R studio. Open field tests were eval-
uated by one-way analysis followed by Tukey’s post hoc test for multiple comparisons. Differences in the balanced beam test and
rotarod were assessed by two-way ANOVA taking time and genotype as numerical and categorical variables. Sampls size estimation
was not performed. For comparison between controls and Bcl11a cko animals, animals were assigned to experimental groups
according to genotypes. No data or subjects were excluded from the analysis, except for experiments involving stereotactical
injections. In this case, subjects were excluded if expression of the protein after viral transduction was not detected in the targeted
region (SNc or VTA). Statistical details are described in the Figure legends, the Results or in the STAR method section (for single cell
RNA-sequencing). P values of less than 0.05 were considered statistically significant. Data are reported as mean values ± standard
error of the mean (SEM).e7 Cell Reports 36, 109697, September 14, 2021
